CPIX: Cumberland Pharmaceuticals Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 74.21
Enterprise Value ($M) 74.22
Book Value ($M) 28.34
Book Value / Share 1.89
Price / Book 2.62
NCAV ($M) -9.72
NCAV / Share -0.65
Price / NCAV -7.64

Profitability (mra)
Return on Invested Capital (ROIC) -0.07
Return on Assets (ROA) -0.04
Return on Equity (ROE) -0.12

Liquidity (mrq)
Quick Ratio 1.09
Current Ratio 1.25

Balance Sheet (mrq) ($M)
Current Assets 31.88
Assets 69.94
Liabilities 41.60
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 37.87
Operating Income -6.43
Net Income -6.48
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -0.61
Cash from Investing 0.06
Cash from Financing 0.20

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
05-15 13G Ikarian Capital, LLC 4.90
04-24 13G/A Integrated Core Strategies (us) Llc 5.80 -34.14
02-13 13G Kazimi A J 40.80 -0.89

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2025-03-07 10-K ____________________________________________________________________________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
2024-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-30 1,729 21,004 8.23
2025-05-29 11,469 85,588 13.40
2025-05-28 16,334 70,362 23.21
2025-05-27 2,851 35,849 7.95

(click for more detail)

Similar Companies
CGON – CG Oncology, Inc. COGT – Cogent Biosciences, Inc.
COLL – Collegium Pharmaceutical, Inc. CRBU – Caribou Biosciences, Inc.
CRGX – CARGO Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io